Press release
Implantable drug delivery devices – Bid good bye to painful needles
Increase in acceptance and patient compliance for implantable drug delivery devices to propel the market
Implantable drug delivery devices offer several advantages over conventional oral or parenteral dosage form such as protection against gastrointestinal tract denaturation and higher absorption across the wall of intestine or stomach. Secondly, the amount of drug reaching the target should be large to obtain the desired therapeutic effect. Another factor that increases acceptance and patient compliance over traditional mode of administration of drug is the biodegradable systems which have gain momentum over non-biodegradable delivery system due to the fact that inert polymer used for the fabrications of the device eventually gets absorbed and excreted by the body alleviating the need of surgical removal of implant after therapy. These factors together are expected to propel the market growth in future forecast. Moreover, factors like device failure, and biocompatibility is expected to restrain the overall market growth.
The global implantable drug delivery device market was valued at US$ 9,554.4 million in 2016 and is expected to witness a robust CAGR of 7.6 % over the forecast period (2017-2025).
Request For Sample Copy@
https://www.coherentmarketinsights.com/insight/request-sample/1103
Increase in global burden of non-communicable diseases is expected to propel implantable drug delivery devices market
According to a report by World Health Organization (WHO), 2017, chronic diseases are the major cause of disabilities worldwide. The estimated global burden by 2020 is 60%. Moreover, 73% of deaths in 2020 is expected to be due to chronic diseases. Four of the most prominent chronic diseases are cardiovascular, cancer, pulmonary and type 2 diabetes. Implantable drug delivery devices offers unique patients solutions for chronic diseases. For instance, in October, 2017, Encellin, has received an exclusive worldwide right for a proprietary cell encapsulated technology by developed UC San Francisco aiming to improve cell transplant without the need of immunosuppressive drugs. The Encellin device is encapsulated with glucose sensitive islet cells in a pouch, and is implanted under the skin, enabling it to regulate glucose level. Similarly, In 2015 Intarcia Therapeutics, developed a drug eluting non-biodegradable device ITC650 for the treatment of diabetes, which consists of osmotic pump small titanium alloy reservoir delivering a steady flow of a glucagon-like peptide-1 receptor agonist, for 12 months.
Geographically, North America is expected to be the dominating region globally in implantable drug delivery devices market owing to high demand for self-administration products and new product launches in this region. For instance, in 2016, U.S. FDA approved V-Go, a wearable 24 hour subcutaneous insulin delivery device by Medtronic for diabetes management, which have helped diabetes treatment outcome. The major market players in the global implantable drug delivery devices market include Boston Scientific, Abbott Laboratories, Medtronic, Merck & Co., Bausch & Lomb Inc., Allergan, Inc., Psivida Corp., and Bayer Healthcare.
Get More Details On this Report:
https://www.coherentmarketinsights.com/market-insight/implantable-drug-delivery-devices-market-1103
About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.
Contact Us:
Mr.Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email:sales@coherentmarketinsights.com
Visit our news Website: http://www.coherentnews.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Implantable drug delivery devices – Bid good bye to painful needles here
News-ID: 920876 • Views: …
More Releases from Medical Device By CMI
Custom Procedure Trays and Packs Market – Insights
Increasing number of surgical procedures is fuelling the adoption of custom procedure trays and packs (CPTP) market during the forecast period. For instance, according to the WHO, global volume of the surgeries performed in 2012 was estimated to 266.2 to 359.5 million, out of which one in every 20 operations globally was done in very-low-expenditure Member States.
Increase in geriatric population, who are more likely to develop chronic wounds as they…
Robotic Rehabilitation and Assistive Technologies Market, By Product Type
Rehabilitation robotics and assistive technologies allow for use of robotic devices for rehabilitation of patients suffering from mobility issues. Robotic rehabilitation and assistive technologies allow for application of robotics in therapeutic procedures to help with recovery a person from various diseases or disabilities such orthopedic traumas, neuromotor disorders, cognitive diseases, strokes and spinal cord injury. Assistive robotics allows people suffering from degenerative motor and/or cognitive abilities to lead an independent…
Spectrophotometer Market : Moving Towards a Brighter Future
North America is expected to hold dominant position in the market and is also expected to show significant growth in the spectrometer market, due to increasing launch of novel products in the region by key players. For instance, in February 2018, Thermo Fisher Scientific, a U.S.-based company, launched TSQ 9000 Triple Quadrupole GC-MS/MS System. This system has been designed to increase productivity, with enhanced sensitivity, and it also reduces maintenance…
Clinical Mass Spectrometry: Innovative Solution for Diverse Medical Applications
Clinical Mass Spectrometry: Innovative Solution for Diverse Medical Applications
Clinical mass spectrometry serves as a quantitative and qualitative analytical tool for assessment of complex mixtures in all the phases of drug development, including identification of the lead compound and their conformational details. Clinical laboratories use automation for the management of large number of samples through, either total automation systems or high level analyzer automation that are offered by clinical mass spectrometers…
More Releases for Implantable
Nanotechnology in Medical Devices Market 2028 by Implantable Materials, Active I …
The Insight Partners analysts forecasts the latest report on “Global Nanotechnology in Medical Devices Market (Covid-19) Impact and Analysis by 2028”, according to report; The Nanotechnology in Medical Devices Market report covers the overall and all-inclusive analysis of Market with all its factors that have an impact on market growth. This report is anchored on the thorough qualitative and quantitative assessment of the Nanotechnology in Medical Devices Market.
The study…
Nanomedical Devices Market Highest CAGR of 10.29% by 2023 | By Types Implantable …
The Global Nano Medical Devices Market is expected to grow at a CAGR of 10.29% during Forecasted Period 2017-2023.
Nanomedical Devices Market - Segmentation
The global Nanomedical Devices Market has been segmented on the basis of applications, end users, types, and lastly region. As per application-based segmentation, this market has been segmented into disease treatment & diagnosis, drug release regulation and other. Disease treatment & diagnosis has been sub-segmented into cancer, cardiovascular…
Nanomedical Devices Market Highest CAGR of 10.29% by 2023 | By Types Implantable …
Nanomedical Devices Market - Segmentation
The global nanomedical devices market has been segmented on the basis of applications, end users, types, and lastly region. As per application-based segmentation, this market has been segmented into disease treatment & diagnosis, drug release regulation and other. Disease treatment & diagnosis has been sub-segmented into cancer, cardiovascular diseases neurological diseases, and other. With regards to end users, the market has been segmented into clinics, hospitals,…
Active Implantable Medical Devices Market (Implantable Cardioverter Defibrillato …
Global Active Implantable Medical Devices Market 2018 report includes Active Implantable Medical Devices Market Size, Revenue, market Share, Active Implantable Medical Devices industry volume, market Trends, Active Implantable Medical Devices Growth aspects. A wide range of applications, Utilization ratio, Supply and demand analysis are also consist in the report. It shows manufacturing capacity, Active Implantable Medical Devices Price during the Forecast period from 2018 to 2025.
For In depth Information Get…
Active Implantable Medical Devices Market by Product Type (Pacemaker, Implantabl …
The Global Active Implantable Medical Devices Market by product type (pacemaker, implantable cardioverter defibrillator, cardiac resynchronization therapy devices, neurostimulator, drug infusion pump, implantable loop recorder, cochlear implant, and others), and region (North America, Latin America, Europe, Asia Pacific, the Middle East, and Africa) was valued at US$ 16,721.2 million in 2016 and is projected to exhibit a CAGR of 5.4% over the forecast period (2017–2025), as highlighted in a new…
Implantable Cardioverter Defibrillators Contribute Largest Revenue to the Global …
According to the study, the global active implantable medical devices market is likely to grow from $17.0 billion in 2016 to $28.9 billion by 2023. Technological advancements, increasing prevalence of cardiovascular diseases, rising healthcare expenditures and increasing research and development activities have been driving the growth of the global active implantable medical devices market. The market is further expected to gain revenue due to increasing geriatric population and incidence of…
